The Alice in Wonderland mushroom is being sold online with vague promises of better health. Buyer beware.
Articles on Psilocybin
Displaying 21 - 40 of 53 articles
Researchers found a sharp rise in calls to US poison centers about magic mushrooms coincided with their decriminalization in several US cities and states.
Psilocybin, commonly known as magic mushrooms, has shown promise in treating anorexia in early studies, mostly in rats. But more research is needed to test if it’s safe and effective in humans.
Cannabis and psilocybin – used under supervision – have the potential to work better than current pain treatments, but the research into both has long been hindered by federal legislation.
Substantial economic growth in the psychedelic drugs market has drawn interest from corporations and start-ups. While this may accelerate research, it also sparks concerns about conflicts of interest.
One in seven Canadian veterans is living with PTSD. Developing a psychedelics research program for veterans should be a public health priority.
Can psychedelics assist in recovery from eating disorders? The findings are promising, but patients and doctors need to proceed with caution until there is additional and extensive research.
Psychedelics are an opportunity to do better than our past drug control strategies. Adults should be trusted to make the right decisions, but policymakers should ensure they do so fully informed.
A scholar who studies alternative expressions of spirituality visited secular, atheist and psychedelic churches and interacted with attendees. Here is what he found.
Change in the brain usually comes with plenty of effort over time. Neuroscientists are working to understand how psychedelic drugs provide a shortcut that seems to rely on existing brain systems.
In addition to placebo effects, patients might be motivated to report they have gotten better, even when they haven’t.
From July 1, authorised psychiatrists will be able to prescribe MDMA and psilocybin in some circumstances. Here’s what we’re excited and concerned about.
Psilocybin, the active ingredient in magic mushrooms, is one example of a fungus which can alter the human mind.
Australia is the first country in the world to legalise the medical use of psychedelics. But without a public subsidy, few Australians will be able to afford them.
Receiving a cancer diagnosis and undergoing cancer treatment can be a traumatizing experience. Psychedelics like LSD, psilocybin and MDMA could help alleviate symptoms from cancer-related PTSD.
While ‘The Last of Us’ is a dramatic projection of a deadly fungal outbreak, it is based, if not in reality, in logic. And it’s a reminder that fungal infections are growing more resistant.
The early research suggests the drugs might be effective for some conditions. But scientists have safety concerns.
From July this year, some psychiatrists will be able to prescribe psychedelics to some patients. Responses from experts working in the field are mixed.
Alberta’s new policy on psychedelic-assisted therapy for mental illness may set a precedent that moves Canadians one step closer to accepting psychedelics as medicinal substances.
Today’s psychedelics researchers still have to deal with the fallout of the decadeslong freeze on research. Listen to ‘The Conversation Weekly’ podcast.
Top contributors
-
Senior Lecturer of Addiction, Edith Cowan University
-
Professor and Canada Research Chair in the History of Health & Social Justice, University of Saskatchewan
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Adjunct Professor, Psychiatry, Karolinska Institutet
-
PhD student in Clinical Psychology, York University, Canada
-
Research Scientist, Queen's Health Sciences and Assistant Professor, Department of Psychiatry, Queen's University, Ontario
-
PhD Candidate, Congnitive Neuroscience, University of Toronto
-
Research fellow, Swinburne University of Technology
-
Killam Postdoctoral Research Fellow, Dalhousie University; Queen's University, Ontario
-
Associate Professor, Cognitive Psychology, Leiden University
-
Medicinal Chemist, UNSW
-
Associate Lecturer, School of Psychology, University of Wollongong
-
Adjunct Professor in the School of Child & Youth Care, University of Victoria
-
Professor, Monash University
-
Director Clinical Trials and Professor Cognitive Neuropsychiatry Centre for Mental Health and Brain Sciences, Swinburne University of Technology